Brian Ritchie | LifeSci Advisors |
Sergio Traversa | Chief Executive Officer |
Maged Shenouda | Chief Financial Officer |
Maurizio Fava | Chairman, Harvard Psychiatry Department |
Guofang Li | SVB Securities |
Uy Ear | Mizuho |
Yatin Suneja | Guggenheim Partners |
Andrea Tan | Goldman Sachs |
Andrew Tsai | Jefferies |
Jay Olson | Oppenheimer |
Joon Lee | Truist Securities |
Good afternoon. My name is Kathy, and I'll be your conference operator for today. At this time, I would like to welcome everyone to the Relmada Therapeutics, Inc.
Third Quarter 2022 Earnings Call. All lines have been placed on mute to prevent any background noise.